CANNTAB IS GO, page-17

Ok you all want answers here they are:

Basileus -
You sound like the type of person who spends a lot of time posting instead of investing, you sound like the old economists around Kerry Packers time that said he was gone when he sold Channel 9, like you, they were full of annual reports and echos of each others optinions how very wrong.
Cann Global has build a strong foundation, why do that if you want to pump and dump...your thinking of the good old Capital Mining it had no foundation hence the crash.

"The churlish notion that somehow the merits of a particular post ought to be assessed based on whether a person holds shares"

Oh yes it does, if you constantly speak negatively about a company and yet have no holding, thats like telling other people how to raise their kids when you have none, it goes to credibility.

"CANN GLOBAL LIMITED will be a billion-dollarcompany very soon"

Very easy to substantiate Approx shares on issue - 5,725,486,785 x 0.19 (share price) = Market cap - $1.087 billion.
Is 0.19 a feasibil price..YES... thats my opinion. Based on the history of the Medicinal Cannabis Market in Australia and worldwide trends.

"should holders discount the information presented in the Annual Report and rely on your ... claims?"

NO.... but the real question here is should "holders" listen to you who is an "Advisor" to holders yet holds nothing who talks about information and commercial metrics noted in the last Annual Report, yet who has never spoken to anyone who actually works for and has a substantial stake in the company. Bottom line get on the phone and email and contact both Cann Global and Medcan and for that sake all Cann Global's related companies and make sure you tell them you hold no shares but you are sure they are full of S_it and see how you go. Many posts here are made without personal commitment to the company, if you did have a stake then your comments were valid until you sold after the sale you move to a differrent position essentially your not a player anymore thats why Hot Copper asks for this to help us all locate the commitment of the person commenting.

On a personnal note:
I saw NASDAQ: MRNA in 2020 my wife gave me the heads up about a possible pandemic, I told her thats madness and discarded her advice, later on I realised she was right, like all good husbands eventuall learn their wives are mostly right and pulled my head in and looked at possible investments based on a potential pandemic. I took a $100k stake in Jan 2020, just sold in Sept 2021, my optinion is Cann is a better investment than that. You do the numbers.
Its my opinion based on my own investing strategy all within ASK regulations that CGB is go now.

To
Tahora your post was professional and had substance thanks hope some of my reply to Basileus answers your question.
to
Ex- Oyster Farmer
jcurve
Aussie Eagle
Luke164

In general your posts seem to have a "mist" of suspicion on them, if I have a hidden adgenda it is this. I decided to invest in CGB on top of a holding I have had for over two years, yes I bought substantially higher than the current price but I saw the fundamentals and acted on that. I also had some casual conversations with the directors and email corresspondence and had a gut feeling that they were people of high integrity. Thats it in a nutshell. Why am I posting now, I just made another substantial investment based on my new analysis of their expansion into other markets and their "brains trust" in other words the strategic relationships they have made worldwide and Sholom's global vision. I did not base any of my investment decision on Hot Copper posts, I did my own research.

Aussie Eagle has taken a particular swipe at the Expo committment in France.. well.......its no mystery....we can all read about it in the 2021 September Annual Financial Report laid out in black and white.(see below extract)

Don't forget Pharmocann has Israeli scientistProf. Raphael Mechoulam who is is one of the founding members of the International Association for Cannabinoid Medicines, I suggest a man in his nineties and of this pedigree is not about to waste his time with a Group that is another type of incarnation of Capital Mining......

Time to do some work of your own people, spend a few days with your head in Cann Global make phone calls, send emails. If you are in Sydney go and speak with them and you will find it is ripe to buy and......
"May I reiterate Cantab is go !!"

Yours,
DD


Key Business Developments
"A range of premium, hemp-based skincare products has beendeveloped with our joint venture partner Pharmocann and asoft launch is scheduled in France in October and in Australiain November".

3. SKINCARE

Cann Global has a 50/50 partnership agreement with one ofIsrael’s leading Cannabis companies Pharmocann, to produceand sell advanced cannabis-based formulations, dermatologicaland cosmetic beauty products.Research and testing were completed during the year onthe three premium hemp-based skincare products from thecosmetics range that the Company will launch in Q2 FY22. Theproducts: an oil, serum and a cream product all contain hempseed oil as the primary active ingredient and Australian nativeingredients thereby offering consumers a unique innovative andefficacious organic product.A successful pilot production run was undertaken during theyear and the process for certifying the products as organic hascommenced. A series of other products under this new organichemp-based brand are already being developed to expand thecurrent range.Go to market strategies for Australian sales have been identifiedand mass production is on track for Q3 FY22. A soft launch isscheduled for November 2021 at the virtual Hemp, Health andInnovation Expo and the products will be available for directpurchase via a newly established website for the skincare products.In addition to the soft launch in Australia in November 2021, CannGlobal will also launch its premium hemp-based cosmetic rangein Europe at a B2B CBD Expo in Paris on 16-18 October, where it willshowcase its new range.A specialist distribution consultancy was engaged to advanceexport marketing strategies with South Korea, Japan and Thailandbeing the initial focus of marketing efforts in Asia.